Rankings
▼
Calendar
EWTX Q1 2020 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
EWTX
Edgewise Therapeutics, Inc.
$3B
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-0.16
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$45,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$23M
Cash & Equivalents
-$24M
← FY 2020
All Quarters
Q2 2020 →
